dc.contributor.author | Whiley, Luke | |
dc.contributor.author | Chappell, Katie E. | |
dc.contributor.author | D'Hondt, Ellie | |
dc.contributor.author | Lewis, Matthew R. | |
dc.contributor.author | Jimenez, Beatriz | |
dc.contributor.author | Snowden, Stuart G. | |
dc.contributor.author | Soininen, Hilkka | |
dc.contributor.author | Kloszewska, Iwona | |
dc.contributor.author | Mecocci, Patrizia | |
dc.contributor.author | Tsolaki, Magda | |
dc.contributor.author | Vellas, Bruno | |
dc.contributor.author | Swann, Jonathan R. | |
dc.contributor.author | Hye, Abdul | |
dc.contributor.author | Lovestone, Simon | |
dc.contributor.author | Legido-Quigley, Cristina | |
dc.contributor.author | Holmes, Elaine | |
dc.date.accessioned | 2022-02-23T15:33:33Z | |
dc.date.available | 2022-02-23T15:33:33Z | |
dc.date.issued | 2021 | |
dc.identifier.issn | 1758-9193 | |
dc.identifier.other | WOS:000606419700001 | |
dc.identifier.uri | https://imec-publications.be/handle/20.500.12860/39062 | |
dc.source | WOS | |
dc.title | Metabolic phenotyping reveals a reduction in the bioavailability of serotonin and kynurenine pathway metabolites in both the urine and serum of individuals living with Alzheimer's disease | |
dc.type | Journal article | |
dc.contributor.imecauthor | D'Hondt, Ellie | |
dc.contributor.orcidext | Whiley, Luke::0000-0002-9088-4799 | |
dc.contributor.orcidext | Lewis, Matthew R.::0000-0001-5760-5359 | |
dc.contributor.orcidext | Swann, Jonathan R.::0000-0002-6485-4529 | |
dc.contributor.orcidext | Hye, Abdul::0000-0003-2237-4823 | |
dc.contributor.orcidext | Legido-Quigley, Cristina::0000-0002-4018-214X | |
dc.contributor.orcidimec | D'Hondt, Ellie::0000-0002-1451-4569 | |
dc.identifier.doi | 10.1186/s13195-020-00741-z | |
dc.source.numberofpages | 18 | |
dc.source.peerreview | yes | |
dc.source.journal | ALZHEIMERS RESEARCH & THERAPY | |
dc.identifier.pmid | MEDLINE:33422142 | |
dc.source.issue | 1 | |
dc.source.volume | 13 | |
imec.availability | Published - open access | |